[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335688-105":59,"doc-detail-335688-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","metal-oxide-nanoparticles-as-efficient-nanocarriers-for-targeted-cancer-therapy-addressing-chemotherapy-induced-disabilities","Metal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy - Addressing Chemotherapy-Induced Disabilities","","Cancer is a major global health challenge, and conventional therapies—especially chemotherapy—are limited by low selectivity, poor solubility, and multidrug resistance, which reduce outcomes and increase adverse effects. Metal oxide nanoparticles (MONPs) such as iron oxide, zinc oxide, and copper oxide are promising nanocarriers that improve targeted drug delivery, lower systemic toxicity, and help mitigate chemotherapy-induced disabilities including neurotoxicity and cardiotoxicity. Drug-conjugated nanocarriers support circulation, imaging, stability, and controlled release, reducing off-target effects and overcoming resistance. This review also examines recent MONP synthesis and functionalization advances aimed at enhancing biocompatibility, drug-loading capacity, and compatibility for potential clinical translation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/metal-oxide-nanoparticles-as-efficient-nanocarriers-for-targeted-cancer-therapy-addressing-chemotherapy-induced-disabilities/335688/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/metal-oxide-nanoparticles-as-efficient-nanocarriers-for-targeted-cancer-therapy-addressing-chemotherapy-induced-disabilities/335688.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is conventional chemotherapy limited in cancer treatment?","Question",{"text":113,"@type":114},"Conventional chemotherapy often suffers from low selectivity, insufficient solubility, and multidrug resistance, which reduce effectiveness and can worsen negative effects.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do metal oxide nanoparticles (MONPs) support targeted cancer therapy?",{"text":118,"@type":114},"MONPs can enhance targeted drug delivery, improve circulation and stability, enable imaging, and support focused, controlled drug release to reduce off-target effects.",{"name":120,"@type":111,"acceptedAnswer":121},"Which chemotherapy-induced disabilities does the review highlight as key targets?",{"text":122,"@type":114},"The review emphasizes chemotherapy-induced neurotoxicity and cardiotoxicity, along with broader disabilities affecting physical, cognitive, and emotional well-being.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335688,1790143632,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nMetal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy: Addressing Chemotherapy-Induced Disabilities  \nMohamed Taha Yassin 1,2, *, Fatimah O. Al-Otibi 1, Sarah A. Al-Sahli 1, Mohammad S. El-Wetidy 3 and Sara Mohamed 4  \nCitation: Yassin, M.T.; Al-Otibi, F.O.; Al-Sahli, S.A.; El-Wetidy, M.S.; Mohamed, S. Metal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy: Addressing Chemotherapy-Induced Disabilities. Cancers 2024, 16, 4234. [https://](https://)[ ](https://)[doi.org/10.3390/cancers16244234](doi.org/10.3390/cancers16244234)  \nAcademic Editor: Clare Hoskins  \nReceived: 14 November 2024  \nRevised: 11 December 2024  \nAccepted: 16 December 2024  \nPublished: 19 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; [falotibi@ksu.edu.sa](falotibi@ksu.edu.sa) (F.O.A.-O.); [445205521@student.ksu.edu.sa](445205521@student.ksu.edu.sa) (S.A.A.-S.)  \n2 King Salman Center for Disability Research, Riyadh 11614, Saudi Arabia  \n3 College of Medicine Research Center, King Saud University, Riyadh 11451, Saudi Arabia; [melwatidy@ksu.edu.sa](melwatidy@ksu.edu.sa)  \n4 Botany and Microbiology Department, Faculty of Science, Benha University, Benha 13511, Egypt; [sara.m.elsayed@gmail.com](sara.m.elsayed@gmail.com)  \n* [Correspondence: myassin2.c@ksu.edu.sa](Correspondence: myassin2.c@ksu.edu.sa)  \nSimple Summary: This research reviews the potential of metal oxide nanoparticles (MONPs) for targeted cancer treatment, addressing the limitations of traditional chemotherapy, such as low selectivity, drug resistance, and toxicity. MONPs like titanium, iron, zinc, and copper oxides show promise in enhancing drug delivery and imaging, enabling focused drug release and improved therapeutic outcomes. However, challenges remain in production scalability, regulatory hurdles, and ensuring biocompatibility and safety. Continued advancements in nanoparticle engineering may bring MONP-based drug delivery closer to being used in effective clinical applications, potentially transforming cancer treatment.  \nAbstract: Cancer remains a predominant global health concern, necessitating effective treatment options. Conventional cancer therapies, particularly chemotherapy, often face constraints such as low selectivity, insufficient solubility, and multidrug resistance (MDR), which diminish effectiveness and exacerbate negative effects. Metal oxide nanoparticles (MONPs), such as iron oxide, zinc oxide, and copper oxide, offer a promising solution by enhancing targeted drug delivery, reducing systemic toxicity, and mitigating chemotherapy-induced disabilities like neurotoxicity and cardiotoxicity. Nanocarriers conjugated with drugs can improve drug delivery within the body and enhance their circulation in the bloodstream. Recent advancements in MONP synthesis and functionalization have further improved their stability and drug-loading capacity, making them a valuable tool in cancer treatment. MONPs have distinctive physicochemical characteristics, enabling better imaging, drug encapsulation, and targeted medication delivery to cancerous cells. These nanocarriers enhance treatment effectiveness through focused and controlled drug release, reducing off-target effects and addressing drug resistance. This review aims to explore the potential of MONPs as efficient nanocarriers for anticancer drugs, addressing limitations of traditional chemotherapy such as poor specificity, systemic toxicity, and drug resistance. Additionally, the review discusses recent advancements in MONP synthesis and function","cbCaioHPYeovw0LC","https://ap.wps.com/l/cbCaioHPYeovw0LC","pdf",3709922,26,"English","# 1. Introduction\n## Cancer burden and disability impacts\n## Limitations of conventional chemotherapy","[{\"question\":\"Why is conventional chemotherapy limited in cancer treatment?\",\"answer\":\"Conventional chemotherapy often suffers from low selectivity, insufficient solubility, and multidrug resistance, which reduce effectiveness and can worsen negative effects.\"},{\"question\":\"How do metal oxide nanoparticles (MONPs) support targeted cancer therapy?\",\"answer\":\"MONPs can enhance targeted drug delivery, improve circulation and stability, enable imaging, and support focused, controlled drug release to reduce off-target effects.\"},{\"question\":\"Which chemotherapy-induced disabilities does the review highlight as key targets?\",\"answer\":\"The review emphasizes chemotherapy-induced neurotoxicity and cardiotoxicity, along with broader disabilities affecting physical, cognitive, and emotional well-being.\"}]","Metal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy - Addressing Chemotherapy-Induced Disabilities | PDF",1790011947,66]